🟢 Azitra is trading 6.06% up in pre-market on October 5 with no identified catalyst

Azitra is trading 6.06% higher at $0.14 in pre-market on October 5, with no identified company-specific explanation for the move.

• On October 1, Azitra said its ATR04-484 Phase 1/2 trial could advance to Cohort 2 after a safety review; available reporting does not link that update to the gain.
• Broader indices are slightly lower, so the supplied market context does not explain the rise.